Last reviewed · How we verify
Cariprazine capsule — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Cariprazine capsule (Cariprazine capsule) — Gedeon Richter Plc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Cariprazine capsule TARGET | Cariprazine capsule | Gedeon Richter Plc. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Cariprazine capsule CI watch — RSS
- Cariprazine capsule CI watch — Atom
- Cariprazine capsule CI watch — JSON
- Cariprazine capsule alone — RSS
Cite this brief
Drug Landscape (2026). Cariprazine capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/cariprazine-capsule. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing